Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 58

1.

Prion-related peripheral neuropathy in sporadic Creutzfeldt-Jakob disease.

Baiardi S, Redaelli V, Ripellino P, Rossi M, Franceschini A, Moggio M, Sola P, Ladogana A, Fociani P, Magherini A, Capellari S, Giese A, Caughey B, Caroppo P, Parchi P.

J Neurol Neurosurg Psychiatry. 2018 Oct 24. pii: jnnp-2018-319221. doi: 10.1136/jnnp-2018-319221. [Epub ahead of print]

PMID:
30355606
2.

Cerebrospinal Fluid Total Prion Protein in the Spectrum of Prion Diseases.

Villar-Piqué A, Schmitz M, Lachmann I, Karch A, Calero O, Stehmann C, Sarros S, Ladogana A, Poleggi A, Santana I, Ferrer I, Mitrova E, Žáková D, Pocchiari M, Baldeiras I, Calero M, Collins SJ, Geschwind MD, Sánchez-Valle R, Zerr I, Llorens F.

Mol Neurobiol. 2018 Jul 30. doi: 10.1007/s12035-018-1251-1. [Epub ahead of print]

PMID:
30062673
3.

Age at onset of genetic (E200K) and sporadic Creutzfeldt-Jakob diseases is modulated by the CYP4X1 gene.

Poleggi A, van der Lee S, Capellari S, Puopolo M, Ladogana A, De Pascali E, Lia D, Formato A, Bartoletti-Stella A, Parchi P, van Duijn C, Pocchiari M.

J Neurol Neurosurg Psychiatry. 2018 Dec;89(12):1243-1249. doi: 10.1136/jnnp-2018-318756. Epub 2018 Jul 21.

PMID:
30032116
4.

Genetic Creutzfeldt-Jakob disease.

Ladogana A, Kovacs GG.

Handb Clin Neurol. 2018;153:219-242. doi: 10.1016/B978-0-444-63945-5.00013-1.

PMID:
29887139
5.

Cerebrospinal fluid neurofilament light levels in neurodegenerative dementia: Evaluation of diagnostic accuracy in the differential diagnosis of prion diseases.

Zerr I, Schmitz M, Karch A, Villar-Piqué A, Kanata E, Golanska E, Díaz-Lucena D, Karsanidou A, Hermann P, Knipper T, Goebel S, Varges D, Sklaviadis T, Sikorska B, Liberski PP, Santana I, Ferrer I, Zetterberg H, Blennow K, Calero O, Calero M, Ladogana A, Sánchez-Valle R, Baldeiras I, Llorens F.

Alzheimers Dement. 2018 Jun;14(6):751-763. doi: 10.1016/j.jalz.2017.12.008. Epub 2018 Feb 3.

PMID:
29391125
6.

The CSF neurofilament light signature in rapidly progressive neurodegenerative dementias.

Abu-Rumeileh S, Capellari S, Stanzani-Maserati M, Polischi B, Martinelli P, Caroppo P, Ladogana A, Parchi P.

Alzheimers Res Ther. 2018 Jan 11;10(1):3. doi: 10.1186/s13195-017-0331-1.

7.

Towards an early clinical diagnosis of sporadic CJD VV2 (ataxic type).

Baiardi S, Magherini A, Capellari S, Redaelli V, Ladogana A, Rossi M, Tagliavini F, Pocchiari M, Giaccone G, Parchi P.

J Neurol Neurosurg Psychiatry. 2017 Sep;88(9):764-772. doi: 10.1136/jnnp-2017-315942. Epub 2017 Jul 1.

PMID:
28668775
8.

Prion Strain Characterization of a Novel Subtype of Creutzfeldt-Jakob Disease.

Galeno R, Di Bari MA, Nonno R, Cardone F, Sbriccoli M, Graziano S, Ingrosso L, Fiorini M, Valanzano A, Pasini G, Poleggi A, Vinci R, Ladogana A, Puopolo M, Monaco S, Agrimi U, Zanusso G, Pocchiari M.

J Virol. 2017 May 12;91(11). pii: e02390-16. doi: 10.1128/JVI.02390-16. Print 2017 Jun 1.

9.

Prion-specific and surrogate CSF biomarkers in Creutzfeldt-Jakob disease: diagnostic accuracy in relation to molecular subtypes and analysis of neuropathological correlates of p-tau and Aβ42 levels.

Lattanzio F, Abu-Rumeileh S, Franceschini A, Kai H, Amore G, Poggiolini I, Rossi M, Baiardi S, McGuire L, Ladogana A, Pocchiari M, Green A, Capellari S, Parchi P.

Acta Neuropathol. 2017 Apr;133(4):559-578. doi: 10.1007/s00401-017-1683-0. Epub 2017 Feb 15.

10.

Extended and direct evaluation of RT-QuIC assays for Creutzfeldt-Jakob disease diagnosis.

Groveman BR, Orrú CD, Hughson AG, Bongianni M, Fiorini M, Imperiale D, Ladogana A, Pocchiari M, Zanusso G, Caughey B.

Ann Clin Transl Neurol. 2016 Dec 27;4(2):139-144. doi: 10.1002/acn3.378. eCollection 2017 Feb.

11.

Diagnosis of Human Prion Disease Using Real-Time Quaking-Induced Conversion Testing of Olfactory Mucosa and Cerebrospinal Fluid Samples.

Bongianni M, Orrù C, Groveman BR, Sacchetto L, Fiorini M, Tonoli G, Triva G, Capaldi S, Testi S, Ferrari S, Cagnin A, Ladogana A, Poleggi A, Colaizzo E, Tiple D, Vaianella L, Castriciano S, Marchioni D, Hughson AG, Imperiale D, Cattaruzza T, Fabrizi GM, Pocchiari M, Monaco S, Caughey B, Zanusso G.

JAMA Neurol. 2017 Feb 1;74(2):155-162. doi: 10.1001/jamaneurol.2016.4614.

PMID:
27942718
12.

Patient with rapidly evolving neurological disease with neuropathological lesions of Creutzfeldt-Jakob disease, Lewy body dementia, chronic subcortical vascular encephalopathy and meningothelial meningioma.

Vita MG, Tiple D, Bizzarro A, Ladogana A, Colaizzo E, Capellari S, Rossi M, Parchi P, Masullo C, Pocchiari M.

Neuropathology. 2017 Apr;37(2):110-115. doi: 10.1111/neup.12343. Epub 2016 Sep 16.

PMID:
27634418
13.

Quantifying prion disease penetrance using large population control cohorts.

Minikel EV, Vallabh SM, Lek M, Estrada K, Samocha KE, Sathirapongsasuti JF, McLean CY, Tung JY, Yu LP, Gambetti P, Blevins J, Zhang S, Cohen Y, Chen W, Yamada M, Hamaguchi T, Sanjo N, Mizusawa H, Nakamura Y, Kitamoto T, Collins SJ, Boyd A, Will RG, Knight R, Ponto C, Zerr I, Kraus TF, Eigenbrod S, Giese A, Calero M, de Pedro-Cuesta J, Haïk S, Laplanche JL, Bouaziz-Amar E, Brandel JP, Capellari S, Parchi P, Poleggi A, Ladogana A, O'Donnell-Luria AH, Karczewski KJ, Marshall JL, Boehnke M, Laakso M, Mohlke KL, Kähler A, Chambert K, McCarroll S, Sullivan PF, Hultman CM, Purcell SM, Sklar P, van der Lee SJ, Rozemuller A, Jansen C, Hofman A, Kraaij R, van Rooij JG, Ikram MA, Uitterlinden AG, van Duijn CM; Exome Aggregation Consortium (ExAC), Daly MJ, MacArthur DG.

Sci Transl Med. 2016 Jan 20;8(322):322ra9. doi: 10.1126/scitranslmed.aad5169.

14.

Revisiting the Heidenhain Variant of Creutzfeldt-Jakob Disease: Evidence for Prion Type Variability Influencing Clinical Course and Laboratory Findings.

Baiardi S, Capellari S, Ladogana A, Strumia S, Santangelo M, Pocchiari M, Parchi P.

J Alzheimers Dis. 2016;50(2):465-76. doi: 10.3233/JAD-150668.

15.

Early-onset spastic paraparesis as presenting sign of familial Creutzfeldt-Jakob disease.

Conte F, Giordano A, Tortora F, Caiazzo G, Ladogana A, Tedeschi G, Tessitore A.

Parkinsonism Relat Disord. 2015 Dec;21(12):1479-80. doi: 10.1016/j.parkreldis.2015.10.004. Epub 2015 Oct 22. No abstract available.

PMID:
26578040
16.

Validation of 14-3-3 Protein as a Marker in Sporadic Creutzfeldt-Jakob Disease Diagnostic.

Schmitz M, Ebert E, Stoeck K, Karch A, Collins S, Calero M, Sklaviadis T, Laplanche JL, Golanska E, Baldeiras I, Satoh K, Sanchez-Valle R, Ladogana A, Skinningsrud A, Hammarin AL, Mitrova E, Llorens F, Kim YS, Green A, Zerr I.

Mol Neurobiol. 2016 May;53(4):2189-99. doi: 10.1007/s12035-015-9167-5. Epub 2015 May 7.

PMID:
25947081
17.

A genome wide association study links glutamate receptor pathway to sporadic Creutzfeldt-Jakob disease risk.

Sanchez-Juan P, Bishop MT, Kovacs GG, Calero M, Aulchenko YS, Ladogana A, Boyd A, Lewis V, Ponto C, Calero O, Poleggi A, Carracedo Á, van der Lee SJ, Ströbel T, Rivadeneira F, Hofman A, Haïk S, Combarros O, Berciano J, Uitterlinden AG, Collins SJ, Budka H, Brandel JP, Laplanche JL, Pocchiari M, Zerr I, Knight RS, Will RG, van Duijn CM.

PLoS One. 2015 Apr 28;10(4):e0123654. doi: 10.1371/journal.pone.0123654. eCollection 2014.

18.

Rethinking of doxycycline therapy in Creutzfeldt-Jakob disease.

Pocchiari M, Ladogana A.

J Neurol Neurosurg Psychiatry. 2015 Jul;86(7):705. doi: 10.1136/jnnp-2014-310127. Epub 2015 Jan 28. No abstract available.

PMID:
25632154
19.

Creutzfeldt-Jakob disease masked by head trauma and features of Wilson's disease.

Scontrini A, Di Bonaventura C, Fiorelli M, Tiple D, Colaizzo E, Ladogana A, Parchi P, Pocchiari M.

Int J Neurosci. 2015 Apr;125(4):312-4. doi: 10.3109/00207454.2014.992428. Epub 2015 Jan 7.

PMID:
25485669
20.

Mutant PrPCJD prevails over wild-type PrPCJD in the brain of V210I and R208H genetic Creutzfeldt-Jakob disease patients.

Cardone F, Principe S, Schininà ME, Maras B, Capellari S, Parchi P, Notari S, Di Francesco L, Poleggi A, Galeno R, Vinci R, Mellina V, Almonti S, Ladogana A, Pocchiari M.

Biochem Biophys Res Commun. 2014 Nov 14;454(2):289-94. doi: 10.1016/j.bbrc.2014.10.051. Epub 2014 Oct 19.

PMID:
25450391
21.

Age at Death of Creutzfeldt-Jakob disease in subsequent family generation carrying the E200K mutation of the prion protein gene.

Pocchiari M, Poleggi A, Puopolo M, D'Alessandro M, Tiple D, Ladogana A.

PLoS One. 2013;8(4):e60376. doi: 10.1371/journal.pone.0060376. Epub 2013 Apr 2.

22.

Cerebrospinal fluid biomarker supported diagnosis of Creutzfeldt-Jakob disease and rapid dementias: a longitudinal multicentre study over 10 years.

Stoeck K, Sanchez-Juan P, Gawinecka J, Green A, Ladogana A, Pocchiari M, Sanchez-Valle R, Mitrova E, Sklaviadis T, Kulczycki J, Slivarichova D, Saiz A, Calero M, Knight R, Aguzzi A, Laplanche JL, Peoc'h K, Schelzke G, Karch A, van Duijn CM, Zerr I.

Brain. 2012 Oct;135(Pt 10):3051-61. doi: 10.1093/brain/aws238. Epub 2012 Sep 25.

23.

Increased levels of acute-phase inflammatory proteins in plasma of patients with sporadic CJD.

Fratini F, Principe S, Puopolo M, Ladogana A, Poleggi A, Piscopo P, Bruno G, Castrechini S, Pascone R, Confaloni A, Minghetti L, Cardone F, Pocchiari M, Crescenzi M.

Neurology. 2012 Sep 4;79(10):1012-8. doi: 10.1212/WNL.0b013e318265a55d. Epub 2012 Aug 1.

PMID:
22855863
24.

Iatrogenic Creutzfeldt-Jakob disease, final assessment.

Brown P, Brandel JP, Sato T, Nakamura Y, MacKenzie J, Will RG, Ladogana A, Pocchiari M, Leschek EW, Schonberger LB.

Emerg Infect Dis. 2012 Jun;18(6):901-7. doi: 10.3201/eid1806.120116.

25.

Health professions and risk of sporadic Creutzfeldt-Jakob disease, 1965 to 2010.

Alcalde-Cabero E, Almazan-Isla J, Brandel JP, Breithaupt M, Catarino J, Collins S, Hayback J, Hoftberger R, Kahana E, Kovacs GG, Ladogana A, Mitrova E, Molesworth A, Nakamura Y, Pocchiari M, Popovic M, Ruiz-Tovar M, Taratuto A, van Duijn C, Yamada M, Will RG, Zerr I, de Pedro Cuesta J.

Euro Surveill. 2012 Apr 12;17(15). pii: 20144. Review.

26.

Transmission of sporadic Creutzfeldt-Jakob disease by blood transfusion: risk factor or possible biases.

Puopolo M, Ladogana A, Vetrugno V, Pocchiari M.

Transfusion. 2011 Jul;51(7):1556-66. doi: 10.1111/j.1537-2995.2010.03004.x. Epub 2011 Jan 7.

PMID:
21214582
27.

Updated clinical diagnostic criteria for sporadic Creutzfeldt-Jakob disease.

Zerr I, Kallenberg K, Summers DM, Romero C, Taratuto A, Heinemann U, Breithaupt M, Varges D, Meissner B, Ladogana A, Schuur M, Haik S, Collins SJ, Jansen GH, Stokin GB, Pimentel J, Hewer E, Collie D, Smith P, Roberts H, Brandel JP, van Duijn C, Pocchiari M, Begue C, Cras P, Will RG, Sanchez-Juan P.

Brain. 2009 Oct;132(Pt 10):2659-68. doi: 10.1093/brain/awp191. Epub 2009 Sep 22. Erratum in: Brain. 2012 Apr;135(Pt 4):1335.

28.

Incidence and spectrum of sporadic Creutzfeldt-Jakob disease variants with mixed phenotype and co-occurrence of PrPSc types: an updated classification.

Parchi P, Strammiello R, Notari S, Giese A, Langeveld JP, Ladogana A, Zerr I, Roncaroli F, Cras P, Ghetti B, Pocchiari M, Kretzschmar H, Capellari S.

Acta Neuropathol. 2009 Nov;118(5):659-71. doi: 10.1007/s00401-009-0585-1. Epub 2009 Aug 29.

29.

Cerebrospinal fluid biomarkers in human genetic transmissible spongiform encephalopathies.

Ladogana A, Sanchez-Juan P, Mitrová E, Green A, Cuadrado-Corrales N, Sánchez-Valle R, Koscova S, Aguzzi A, Sklaviadis T, Kulczycki J, Gawinecka J, Saiz A, Calero M, van Duijn CM, Pocchiari M, Knight R, Zerr I.

J Neurol. 2009 Oct;256(10):1620-8. doi: 10.1007/s00415-009-5163-x. Epub 2009 May 15.

30.

Creutzfeldt-Jakob disease: hopes for therapy.

Pocchiari M, Ladogana A, Graziano S, Puopolo M.

Eur J Neurol. 2008 May;15(5):435-6. doi: 10.1111/j.1468-1331.2008.02109.x. No abstract available.

PMID:
18394045
31.

Influence of timing on CSF tests value for Creutzfeldt-Jakob disease diagnosis.

Sanchez-Juan P, Sánchez-Valle R, Green A, Ladogana A, Cuadrado-Corrales N, Mitrová E, Stoeck K, Sklaviadis T, Kulczycki J, Hess K, Krasnianski A, Equestre M, Slivarichová D, Saiz A, Calero M, Pocchiari M, Knight R, van Duijn CM, Zerr I.

J Neurol. 2007 Jul;254(7):901-6. Epub 2007 Mar 25.

32.

CSF analysis in patients with sporadic CJD and other transmissible spongiform encephalopathies.

Green A, Sanchez-Juan P, Ladogana A, Cuadrado-Corrales N, Sánchez-Valle R, Mitrová E, Stoeck K, Sklaviadis T, Kulczycki J, Heinemann U, Hess K, Slivarichová D, Saiz A, Calero M, Mellina V, Knight R, van Duijn CM, Zerr I.

Eur J Neurol. 2007 Feb;14(2):121-4.

PMID:
17250717
33.

CSF tests in the differential diagnosis of Creutzfeldt-Jakob disease.

Sanchez-Juan P, Green A, Ladogana A, Cuadrado-Corrales N, Sáanchez-Valle R, Mitrováa E, Stoeck K, Sklaviadis T, Kulczycki J, Hess K, Bodemer M, Slivarichová D, Saiz A, Calero M, Ingrosso L, Knight R, Janssens AC, van Duijn CM, Zerr I.

Neurology. 2006 Aug 22;67(4):637-43.

PMID:
16924018
34.

Genetic prion disease: the EUROCJD experience.

Kovács GG, Puopolo M, Ladogana A, Pocchiari M, Budka H, van Duijn C, Collins SJ, Boyd A, Giulivi A, Coulthart M, Delasnerie-Laupretre N, Brandel JP, Zerr I, Kretzschmar HA, de Pedro-Cuesta J, Calero-Lara M, Glatzel M, Aguzzi A, Bishop M, Knight R, Belay G, Will R, Mitrova E; EUROCJD.

Hum Genet. 2005 Nov;118(2):166-74. Epub 2005 Nov 15.

PMID:
16187142
35.

[Creutzfeldt-Jakob disease and other human forms of transmissible spongiform encephalopathy in Italy: a mortality study carried out from different data sources].

Conti S, Masocco M, Solimini R, Toccaceli V, Vichi M, Ladogana A, Almonti S, Puopolo M, Pocchiari M.

Ann Ist Super Sanita. 2005;41(1):103-11. Italian.

36.

High incidence of genetic human transmissible spongiform encephalopathies in Italy.

Ladogana A, Puopolo M, Poleggi A, Almonti S, Mellina V, Equestre M, Pocchiari M.

Neurology. 2005 May 10;64(9):1592-7.

PMID:
15883322
37.

Mortality from Creutzfeldt-Jakob disease and related disorders in Europe, Australia, and Canada.

Ladogana A, Puopolo M, Croes EA, Budka H, Jarius C, Collins S, Klug GM, Sutcliffe T, Giulivi A, Alperovitch A, Delasnerie-Laupretre N, Brandel JP, Poser S, Kretzschmar H, Rietveld I, Mitrova E, Cuesta Jde P, Martinez-Martin P, Glatzel M, Aguzzi A, Knight R, Ward H, Pocchiari M, van Duijn CM, Will RG, Zerr I.

Neurology. 2005 May 10;64(9):1586-91.

PMID:
15883321
38.

Mortality from human transmissible spongiform encephalopathies: a record linkage study.

Conti S, Masocco M, Toccaceli V, Vichi M, Ladogana A, Almonti S, Puopolo M, Pocchiari M.

Neuroepidemiology. 2005;24(4):214-20. Epub 2005 Apr 12.

PMID:
15832059
39.

Predictors of survival in sporadic Creutzfeldt-Jakob disease and other human transmissible spongiform encephalopathies.

Pocchiari M, Puopolo M, Croes EA, Budka H, Gelpi E, Collins S, Lewis V, Sutcliffe T, Guilivi A, Delasnerie-Laupretre N, Brandel JP, Alperovitch A, Zerr I, Poser S, Kretzschmar HA, Ladogana A, Rietvald I, Mitrova E, Martinez-Martin P, de Pedro-Cuesta J, Glatzel M, Aguzzi A, Cooper S, Mackenzie J, van Duijn CM, Will RG.

Brain. 2004 Oct;127(Pt 10):2348-59. Epub 2004 Sep 10.

40.

Mortality trend from sporadic Creutzfeldt-Jakob disease (CJD) in Italy, 1993-2000.

Puopolo M, Ladogana A, Almonti S, Daude N, Bevivino S, Petraroli R, Poleggi A, Quanguo L, Pocchiari M.

J Clin Epidemiol. 2003 May;56(5):494-9.

PMID:
12812825
41.

Mutation of the PRNP gene at codon 211 in familial Creutzfeldt-Jakob disease.

Ladogana A, Almonti S, Petraroli R, Giaccaglini E, Ciarmatori C, Liù QG, Bevivino S, Squitieri F, Pocchiari M.

Am J Med Genet. 2001 Oct 1;103(2):133-7.

PMID:
11568919
42.

Increased brain synthesis of prostaglandin E2 and F2-isoprostane in human and experimental transmissible spongiform encephalopathies.

Minghetti L, Greco A, Cardone F, Puopolo M, Ladogana A, Almonti S, Cunningham C, Perry VH, Pocchiari M, Levi G.

J Neuropathol Exp Neurol. 2000 Oct;59(10):866-71.

PMID:
11079776
43.

Analysis of EEG and CSF 14-3-3 proteins as aids to the diagnosis of Creutzfeldt-Jakob disease.

Zerr I, Pocchiari M, Collins S, Brandel JP, de Pedro Cuesta J, Knight RS, Bernheimer H, Cardone F, Delasnerie-Lauprêtre N, Cuadrado Corrales N, Ladogana A, Bodemer M, Fletcher A, Awan T, Ruiz Bremón A, Budka H, Laplanche JL, Will RG, Poser S.

Neurology. 2000 Sep 26;55(6):811-5.

PMID:
10994001
44.

Prion protein glycotype analysis in familial and sporadic Creutzfeldt-Jakob disease patients.

Cardone F, Liu QG, Petraroli R, Ladogana A, D'Alessandro M, Arpino C, Di Bari M, Macchi G, Pocchiari M.

Brain Res Bull. 1999 Aug;49(6):429-33.

PMID:
10483920
45.

Creutzfeldt-Jakob disease mortality in Italy, 1982-1996.

Arpino C, Conti S, Masocco M, Toccaceli V, Ladogana A, D'Alessandro M, Pocchiari M.

Neuroepidemiology. 1999;18(2):92-100.

PMID:
10023132
46.

High incidence of Creutzfeldt-Jakob disease in rural Calabria, Italy.

D'Alessandro M, Petraroli R, Ladogana A, Pocchiari M.

Lancet. 1998 Dec 19-26;352(9145):1989-90. No abstract available.

PMID:
9872257
47.

Recent Italian FFI cases.

Pocchiari M, Ladogana A, Petraroli R, Cardone F, D'Alessandro M.

Brain Pathol. 1998 Jul;8(3):564-6. No abstract available.

PMID:
9669712
48.

Proteinase-resistant protein in human neuroblastoma cells infected with brain material from Creutzfeldt-Jakob patient.

Ladogana A, Liu Q, Xi YG, Pocchiari M.

Lancet. 1995 Mar 4;345(8949):594-5. No abstract available.

PMID:
7776812
49.

Congo red prolongs the incubation period in scrapie-infected hamsters.

Ingrosso L, Ladogana A, Pocchiari M.

J Virol. 1995 Jan;69(1):506-8.

50.

Modification of tritiated gamma-amino-n-butyric acid transport in rabies virus-infected primary cortical cultures.

Ladogana A, Bouzamondo E, Pocchiari M, Tsiang H.

J Gen Virol. 1994 Mar;75 ( Pt 3):623-7.

PMID:
8126458

Supplemental Content

Loading ...
Support Center